Oxidative stress and the DNA mismatch repair pathway

Antioxidants and Redox Signaling

Volumn 18, Issue 18, 2013, Pages 2420-2428

  Brierley, David J ^a   Martin, Sarah A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MUTL; PROTEIN MUTS;

DNA DAMAGE; DNA MODIFICATION; EXCISION REPAIR; HUMAN; MAMMAL CELL; MISMATCH REPAIR; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN NEOPLASMS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA ADDUCTS; DNA DAMAGE; DNA MISMATCH REPAIR; GENOMIC INSTABILITY; HUMANS; MUTS DNA MISMATCH-BINDING PROTEIN; NEOPLASTIC SYNDROMES, HEREDITARY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

MAMMALIA;

EID: 84875922320     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4994     Document Type: Review

References (49)

1. Barnes DE and Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 38: 445-476, 2004.
2. Bentz BG, Haines GK, 3rd, and Radosevich JA. Increased protein nitrosylation in head and neck squamous cell carci-nogenesis. Head Neck 22: 64-70, 2000.
3. Broaddus RR, et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 106: 87-94, 2006.
4. Brown NS, et al. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angio-genic factors. Cancer Res 60: 6298-6302, 2000.
5. Bryant HE, et al. Specific killing of BRCA2-deficient tumors with inhibitors of poly(ADP-ribose) polymerase. Nature. 434: 913-917, 2005.
6. Colussi C, et al. The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr Biol 12: 912-918, 2002.
7. Cooke MS, et al. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17: 1195-1214, 2003.
8. DeWeese TL, et al. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxi-dative stress inflicted by low-level radiation. Proc Natl Acad Sci U S A 95: 11915-11920, 1998.
9. Dizdaroglu M, et al. Excision of products of oxidative DNA base damage by human NTH1 protein. Biochemistry 38: 243-246, 1999.
10. Dizdaroglu M, et al. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 32: 1102-1115, 2002.
11. Dizdaroglu M and Jaruga P. Mechanisms of free radical-induced damage to DNA. Free Radic Res 46: 382-419, 2012.
12. Earley MC and Crouse GF. The role of mismatch repair in the prevention of base pair mutations in Saccharomyces cer-evisiae. Proc Natl Acad Sci U S A 95: 15487-15491, 1998.
13. Emerit J, Edeas M, and Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58: 39-46, 2004.
14. Evans MD, Dizdaroglu M, and Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567: 1-61, 2004.
15. Farmer H, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005.
16. Foksinski M, et al. The level of typical biomarker of oxidative stress 8-hydroxy-2'-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor. Free Radic Biol Med 29: 597-601, 2000.
17. Genschel J, et al. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J Biol Chem 273: 19895-19901, 1998.
18. Gradia S, et al. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol Cell 3: 255-261, 1999.
19. Gu L, et al. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair. Nucleic Acids Res 26: 1173-1178, 1998.
20. Gu Y, et al. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J Biol Chem 277: 11135-11142, 2002.
21. Hutsell SQ and Sancar A. Nucleotide excision repair, oxi-dative damage, DNA sequence polymorphisms, and cancer treatment. Clin Cancer Res 11: 1355-1357, 2005.
22. Iyer RR, et al. DNA mismatch repair: functions and mechanisms. Chem Rev 106: 302-323, 2006.
23. Kaelin WG, Jr. The concept of synthetic lethality in the context of anticancer therapy. Nature reviews. Cancer 5: 689-698, 2005.
24. Karihtala P, et al. Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur J Cancer 42: 2653-2659, 2006.
25. Kolodner RD and Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9: 89-96, 1999.
26. Kregel KC and Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 292: R18-R36, 2007.
27. Leadon SA and Avrutskaya AV. Requirement for DNA mismatch repair proteins in the transcription-coupled repair of thymine glycols in Saccharomyces cerevisiae. Mutat Res 407: 177-187, 1998.
28. Macpherson P, et al. 8-oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSalpha. Nucleic Acids Res 33: 5094-5105, 2005.
29. Martin SA, et al. DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer Cell 17: 235-248, 2010.
30. Martin SA, et al. Methotrexate induces oxidative DNA damage and is selectively lethal to tumor cells with defects in the DNA mismatch repair gene MSH2. EMBO Mol Med 1: 323-337, 2009.
31. Martin SA, et al. Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers. Cancer Res 71: 1836-1848, 2011.
32. Martin SA, Lord CJ, and Ashworth A. DNA repair deficiency as a therapeutic target in cancer. Current Opin Genet Dev 18: 80-86, 2008.
33. Mazurek A, Berardini M, and Fishel R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem 277: 8260-8266, 2002.
34. Modrich P and Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65: 101-133, 1996.
35. Musarrat J, Arezina-Wilson J, and Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 32A: 1209-1214, 1996.
36. Ni TT, Marsischky GT, and Kolodner RD. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol Cell 4: 439-444, 1999.
37. O'Brien V and Brown R. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27: 682-692, 2006.
38. Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10: 735-740, 2001.
39. Pfeifer GP, et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21: 7435-7451, 2002.
40. Plotz G, et al. N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha. Nucleic Acids Res 31: 3217-3226, 2003.
41. Slupphaug G, Kavli B, and Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 531: 231-251, 2003.
42. Sommers SC and McManus RG. Multiple arsenical cancers of skin and internal organs. Cancer 6: 347-359, 1953.
43. Stocker R and Keaney Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
44. Svilar D, et al. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid Redox Signal 14: 2491-2507, 2011.
45. Umar A, et al. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87: 65-73, 1996.
46. Wiseman H and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 (Pt 1): 17-29, 1996.
47. Wyrzykowski J and Volkert MR. The Escherichia coli methyl-directed mismatch repair system repairs base pairs containing oxidative lesions. J Bacteriol 185: 1701-1704, 2003.
48. Xie Y, et al. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 64: 3096-3102, 2004.
49. Young LC, et al. DNA mismatch repair protein Msh6 is required for optimal levels of ultraviolet-B-induced apoptosis in primary mouse fibroblasts. J Invest Dermatol 121: 876-880, 2003.